Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.
about
LincRNA-p21: Implications in Human DiseasesResearch progress in the radioprotective effect of the canonical Wnt pathwayRole of the beta catenin destruction complex in mediating chemotherapy-induced senescence-associated secretory phenotypeWNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaThe molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 InteractionCancer stem cells and chemoresistance: The smartest survives the raidLIG4 mediates Wnt signalling-induced radioresistance.Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cellsCCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations.Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.LGR5 positivity defines stem-like cells in colorectal cancer.Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncology.The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.WNT signaling in glioblastoma and therapeutic opportunities.A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.Prognostic significance of DSG3 in rectal adenocarcinoma treated with preoperative chemoradiotherapy.LincRNa-p21: function and mechanism in cancer.Radiation-induced inflammatory cascade and its reverberating crosstalks as potential cause of post-radiotherapy second malignancies.Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast Differentiation.Screening candidate microRNA-mRNA regulatory pairs for predicting the response to chemoradiotherapy in rectal cancer by a bioinformatics approachTo Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer.Targeting progastrin enhances radiosensitization of colorectal cancer cells.Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway.The Wnt signaling pathway is differentially expressed during the bovine herpesvirus 1 latency-reactivation cycle: evidence that two protein kinases associated with neuronal survival (Akt3 and bone morphogenetic protein receptor 2) are expressed at hSTAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.Trichostatin A preferentially reverses the upregulation of gene-expression levels induced by gain of chromosome 7 in colorectal cancer cell lines.Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2.
P2860
Q26798205-5D4A7ED9-56C0-4638-954E-5E8348F9FF12Q28386021-DDDBE551-21FD-4074-ABE7-88D776E86492Q28484422-F66CE018-B00A-4809-B860-92CD1AF80395Q34979270-5588A4CD-11A3-428B-87C1-5AF07DBE929BQ35859128-710F2628-6083-4CA7-8045-0FFAD2E892F1Q35970241-059D8E46-A8D0-43CC-97B6-F2F9BBACFA0CQ36730432-8FC0A82D-CF4E-4EEF-90A6-8A41EDC8FCADQ36765158-06E9F3E1-DC19-47A4-8723-25348497CAFDQ37297635-68B8D6A9-EE7D-4510-BA44-BDD22CF70D04Q37381612-455EE6F7-AA68-49F4-A3BB-2676664DDDBCQ37520468-24BF5B8B-F32C-4575-AE1B-BE8A83E51BF9Q37687330-33B79AE9-DCE5-4450-A4C5-9241F4A7B727Q38127721-1FDAFD76-0B52-49C2-A80F-8789FB62CDB0Q38194616-2C8636E3-2B12-4A35-9CFC-83362DFFF421Q38287226-89DB2C4F-1A07-4960-A685-B9287BD4C1D4Q38660744-257CB4FF-E0B6-4615-ADA1-ACDAA6D02ABDQ38757495-3EDD81BD-5619-4D19-A26A-1581C682AA98Q38886547-62FE9914-0F0B-44A1-A763-E12F9953A5A1Q39251471-2908B8E1-ECB1-4F12-AFAD-EA858A2B828BQ39434440-2593EC8E-4D02-42FD-B728-07A9609F7A20Q39794645-16FBCBC6-4EE3-448A-AE14-CC734985A510Q41197547-6D5FACE3-221E-48A3-B4E0-5333583A3347Q41660291-81F277D5-7412-4069-A92F-A1678AB6DABBQ41709357-4F5B1F85-0985-424D-BF43-3D3569C7F5F8Q45305367-C26EB1D7-0E59-477E-AA2F-4B6F825179A9Q47127087-DB2724C9-EA5A-483B-9146-EE890B326204Q47555859-3214F9EE-16B8-45F7-A49A-EA959DC2AB6EQ47806027-15E19ABB-2718-47D0-B9E8-E510D5D19A19Q48303232-4B10349E-5B4E-4514-B2B8-C14F944069DCQ48692077-352CD55B-3D37-40FF-B86D-0D42E55ED360Q55400650-E010E5BE-3C5D-401A-9FE2-2C94BD29B1A9
P2860
Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Silencing of the Wnt transcrip ...... ells to (chemo-) radiotherapy.
@ast
Silencing of the Wnt transcrip ...... ells to (chemo-) radiotherapy.
@en
type
label
Silencing of the Wnt transcrip ...... ells to (chemo-) radiotherapy.
@ast
Silencing of the Wnt transcrip ...... ells to (chemo-) radiotherapy.
@en
prefLabel
Silencing of the Wnt transcrip ...... ells to (chemo-) radiotherapy.
@ast
Silencing of the Wnt transcrip ...... ells to (chemo-) radiotherapy.
@en
P2093
P2860
P50
P356
P1433
P1476
Silencing of the Wnt transcrip ...... cells to (chemo-) radiotherapy
@en
P2093
B Michael Ghadimi
Emil Kendziorra
Heinz Becker
Hendrik A Wolff
Jochen Gaedcke
Kerstin Ahlborn
Margret Rave-Fränk
Marian Grade
Melanie Spitzner
Reinhard Ebner
P2860
P304
P356
10.1093/CARCIN/BGR222
P407
P577
2011-10-08T00:00:00Z